BRPI0809667A2 - Composto, medicamento e composição farmacêutica que o contém e uso do composto - Google Patents
Composto, medicamento e composição farmacêutica que o contém e uso do compostoInfo
- Publication number
- BRPI0809667A2 BRPI0809667A2 BRPI0809667-8A2A BRPI0809667A BRPI0809667A2 BR PI0809667 A2 BRPI0809667 A2 BR PI0809667A2 BR PI0809667 A BRPI0809667 A BR PI0809667A BR PI0809667 A2 BRPI0809667 A2 BR PI0809667A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- composition containing
- medicinal product
- medicinal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2007051292 | 2007-04-11 | ||
IB2008050746 | 2008-02-29 | ||
PCT/IB2008/051356 WO2008126024A2 (en) | 2007-04-11 | 2008-04-10 | Oxazolidinone antibiotic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0809667A2 true BRPI0809667A2 (pt) | 2014-10-07 |
Family
ID=39722506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0809667-8A2A BRPI0809667A2 (pt) | 2007-04-11 | 2008-04-10 | Composto, medicamento e composição farmacêutica que o contém e uso do composto |
Country Status (16)
Country | Link |
---|---|
US (1) | US8114867B2 (pt) |
EP (1) | EP2146987B1 (pt) |
JP (1) | JP5363457B2 (pt) |
KR (1) | KR101563752B1 (pt) |
CN (1) | CN101657450B (pt) |
AR (1) | AR066012A1 (pt) |
AU (1) | AU2008238894B2 (pt) |
BR (1) | BRPI0809667A2 (pt) |
CA (1) | CA2679069C (pt) |
CL (1) | CL2008001003A1 (pt) |
ES (1) | ES2560870T3 (pt) |
MX (1) | MX2009010641A (pt) |
PL (1) | PL2146987T3 (pt) |
RU (1) | RU2506263C2 (pt) |
TW (1) | TWI415614B (pt) |
WO (1) | WO2008126024A2 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0820985A2 (pt) | 2007-12-18 | 2015-06-16 | Actelion Pharmaceuticals Ltd | Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos |
WO2009104147A2 (en) | 2008-02-20 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Azatricyclic antibiotic compounds |
PL2254887T3 (pl) | 2008-02-22 | 2013-05-31 | Actelion Pharmaceuticals Ltd | Pochodne oksazolidynonu |
AU2009278791A1 (en) * | 2008-08-04 | 2010-02-11 | Actelion Pharmaceuticals Ltd | Tricyclic alkylaminomethyloxazolidinone derivatives |
DK2344495T3 (en) | 2008-10-07 | 2015-02-02 | Actelion Pharmaceuticals Ltd | TRICYCLIC OXAZOLIDINON ANTIBIOTIC COMPOUNDS |
WO2010041219A1 (en) * | 2008-10-10 | 2010-04-15 | Actelion Pharmaceuticals Ltd | 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
CN102232078B (zh) | 2008-12-12 | 2014-07-16 | 埃科特莱茵药品有限公司 | 5-氨基-2-(1-羟基-乙基)-四氢吡喃衍生物 |
EP2509997B1 (en) * | 2009-12-07 | 2017-08-30 | i2 Pharmaceuticals, Inc. | Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties |
EP2377850A1 (en) * | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
TW201309689A (zh) | 2011-02-07 | 2013-03-01 | Daiichi Sankyo Co Ltd | 含胺基之吡咯啶酮衍生物 |
MX2014001680A (es) | 2011-08-11 | 2014-05-27 | Actelion Pharmaceuticals Ltd | Derivados de quinazolina-2, 4-diona. |
TWI594996B (zh) * | 2011-11-08 | 2017-08-11 | 艾克泰聯製藥有限公司 | 2-氧代-唑烷-3,5-二基抗生素衍生物 |
WO2013080156A1 (en) | 2011-11-30 | 2013-06-06 | Actelion Pharmaceuticals Ltd | 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
WO2014024056A1 (en) | 2012-08-06 | 2014-02-13 | Daiichi Sankyo Company, Limited | Pyrrolidine derivatives with antibacterial properties |
EA029143B1 (ru) * | 2012-08-17 | 2018-02-28 | Басф Се | Способ получения бензоксазинонов |
MX362338B (es) | 2013-04-16 | 2019-01-11 | Idorsia Pharmaceuticals Ltd | Derivados biaromaticos antibacterianos. |
AR102256A1 (es) | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
GB201602235D0 (en) * | 2016-02-08 | 2016-03-23 | Redx Pharma Plc | Antibacterial compounds |
EP3414246A1 (en) * | 2016-02-08 | 2018-12-19 | Redx Pharma PLC | Antibacterial compounds |
BR112018016208A2 (pt) | 2016-02-08 | 2018-12-18 | Redx Pharma Plc | compostos heterocíclicos, em particular derivados 2-oxo-4,4,5,5,6,6,7,7-octahidrobenzoxazol, e seus usos como compostos antibacterianos |
GB2550437B (en) | 2016-05-20 | 2021-06-23 | Bugworks Res Inc | Heterocyclic compounds useful as anti-bacterial agents and method for production |
TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
JP7148991B2 (ja) * | 2017-06-08 | 2022-10-06 | バグワークス・リサーチ・インコーポレイテッド | 抗菌剤として有用な複素環式化合物及びその生成方法 |
WO2019106693A1 (en) * | 2017-11-29 | 2019-06-06 | Bugworks Research India Pvt Ltd | Anti-bacterial heterocyclic compounds and their synthesis |
PL3774790T3 (pl) * | 2018-03-28 | 2023-07-31 | Bugworks Research, Inc. | Oksazolidynonowe związki antybiotykowe oraz sposób ich wytwarzania |
CN117532894A (zh) * | 2023-12-05 | 2024-02-09 | 东莞美泰电子有限公司 | 一种用于保护零件的pu皮革热压贴皮工艺 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1064360C (zh) | 1995-04-21 | 2001-04-11 | 新日本药品株式会社 | 稠合咪唑并[1,2-a]吡啶类 |
US5968962A (en) * | 1995-09-01 | 1999-10-19 | Pharmacia & Upjohn Company | Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings |
JP4633925B2 (ja) | 1998-05-08 | 2011-02-16 | スミスクライン ビーチャム ピー エル シー | フェニル尿素およびフェニルチオ尿素誘導体 |
AU2490900A (en) | 1999-01-07 | 2000-07-24 | Wyeth | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
CN1171887C (zh) | 1999-06-28 | 2004-10-20 | 詹森药业有限公司 | 呼吸道合胞病毒复制抑制剂 |
CZ2003243A3 (cs) | 2000-07-26 | 2003-09-17 | Smithkline Beecham P. L. C. | Aminopiperidinové chinoliny a jejich azaisosterické analogy s antibakteriální aktivitou |
GB0031086D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
AU2003224345A1 (en) * | 2002-04-30 | 2003-11-17 | Orchid Chemicals & Pharmaceuticals | Antibacterial agents |
TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
AU2003301414B8 (en) * | 2002-10-10 | 2010-06-17 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Novel compounds with antibacterial activity |
AU2003294565A1 (en) * | 2002-12-04 | 2004-06-23 | Glaxo Group Limited | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
AR042486A1 (es) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
DE10316081A1 (de) | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
EP1484304A1 (en) | 2003-05-28 | 2004-12-08 | Dainippon Ink And Chemicals, Inc. | Process for the preparation of fluorophenylalkylene acid derivatives |
US7691850B2 (en) | 2004-06-15 | 2010-04-06 | Glaxo Group Limited | Antibacterial agents |
FR2872164B1 (fr) * | 2004-06-29 | 2006-11-17 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
EP1771456A2 (fr) * | 2004-07-30 | 2007-04-11 | Palumed SA | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
WO2006032466A2 (en) | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | New bicyclic antibiotics |
JP5314244B2 (ja) | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
GB0426373D0 (en) | 2004-12-01 | 2005-01-05 | Syngenta Ltd | Fungicides |
DE602006016564D1 (de) | 2005-03-03 | 2010-10-14 | Santen Pharmaceutical Co Ltd | Neue cyclische verbindung mit chinolylalkylthiogruppe |
NZ562034A (en) | 2005-03-31 | 2009-10-30 | Janssen Pharmaceutica Nv | Bicyclic pyrazole compounds as antibacterial agents |
WO2007016610A2 (en) | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | Antibacterial agents |
WO2007069555A1 (ja) | 2005-12-12 | 2007-06-21 | Meiji Seika Kaisha, Ltd. | 新規16員環4”-o-カルバモイルアザライド誘導体及びその製造方法 |
ES2376488T3 (es) | 2006-01-26 | 2012-03-14 | Actelion Pharmaceuticals Ltd. | Antibióticos de tetrahidropirano. |
-
2008
- 2008-04-09 CL CL200801003A patent/CL2008001003A1/es unknown
- 2008-04-10 CA CA2679069A patent/CA2679069C/en not_active Expired - Fee Related
- 2008-04-10 AR ARP080101485A patent/AR066012A1/es unknown
- 2008-04-10 CN CN200880011810.XA patent/CN101657450B/zh not_active Expired - Fee Related
- 2008-04-10 BR BRPI0809667-8A2A patent/BRPI0809667A2/pt not_active IP Right Cessation
- 2008-04-10 MX MX2009010641A patent/MX2009010641A/es active IP Right Grant
- 2008-04-10 AU AU2008238894A patent/AU2008238894B2/en not_active Ceased
- 2008-04-10 EP EP08737784.2A patent/EP2146987B1/en not_active Not-in-force
- 2008-04-10 RU RU2009141310/04A patent/RU2506263C2/ru not_active IP Right Cessation
- 2008-04-10 KR KR1020097023303A patent/KR101563752B1/ko active IP Right Grant
- 2008-04-10 WO PCT/IB2008/051356 patent/WO2008126024A2/en active Application Filing
- 2008-04-10 TW TW097113095A patent/TWI415614B/zh not_active IP Right Cessation
- 2008-04-10 ES ES08737784.2T patent/ES2560870T3/es active Active
- 2008-04-10 JP JP2010502625A patent/JP5363457B2/ja not_active Expired - Fee Related
- 2008-04-10 US US12/595,711 patent/US8114867B2/en not_active Expired - Fee Related
- 2008-04-10 PL PL08737784T patent/PL2146987T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
JP5363457B2 (ja) | 2013-12-11 |
AU2008238894A1 (en) | 2008-10-23 |
ES2560870T3 (es) | 2016-02-23 |
WO2008126024A3 (en) | 2008-12-04 |
TW200843780A (en) | 2008-11-16 |
EP2146987A2 (en) | 2010-01-27 |
US20100137290A1 (en) | 2010-06-03 |
AR066012A1 (es) | 2009-07-15 |
AU2008238894B2 (en) | 2013-06-20 |
RU2009141310A (ru) | 2011-05-20 |
MX2009010641A (es) | 2009-10-23 |
WO2008126024A2 (en) | 2008-10-23 |
PL2146987T3 (pl) | 2016-05-31 |
KR20090130112A (ko) | 2009-12-17 |
JP2010523645A (ja) | 2010-07-15 |
EP2146987B1 (en) | 2015-12-02 |
CA2679069A1 (en) | 2008-10-23 |
RU2506263C2 (ru) | 2014-02-10 |
KR101563752B1 (ko) | 2015-10-27 |
CL2008001003A1 (es) | 2008-10-17 |
CN101657450B (zh) | 2014-04-23 |
CN101657450A (zh) | 2010-02-24 |
CA2679069C (en) | 2016-06-07 |
TWI415614B (zh) | 2013-11-21 |
US8114867B2 (en) | 2012-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
BRPI0907892A2 (pt) | Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
BRPI0815079A2 (pt) | Composto dericado de 1,2-diamido-etileno, composição farmacêutica que contém e uso desse composto | |
BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
CL2007002446A1 (es) | Compuestos derivados de morfolino pirimidina; composicion farmaceutica; y su uso para preparar un medicamento para producir un efecto antiproliferante. | |
CL2007002916A1 (es) | Compuestos derivados de pirazoliltienopiridinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en la inhibicion de escaras. | |
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0815190A2 (pt) | Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo | |
BRPI0809346A2 (pt) | Compostos derivados substituídos de imidazopiridina e composição farmacêutica contendo os mesmos | |
BRPI0921699A2 (pt) | complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo | |
BRPI0810399A2 (pt) | Composto, composição farmacêutica que o contém e uso do mesmo | |
BRPI0908208A2 (pt) | Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto. | |
BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
CR10229A (es) | Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
IL206562A0 (en) | Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition | |
BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0916571A2 (pt) | composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto | |
BRPI0812942A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
BRPI0820985A2 (pt) | Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos | |
BRPI0720684A2 (pt) | composto, medicamento, composição farmacêutica que contém e uso do composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B25C | Requirement related to requested transfer of rights |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B25B | Requested transfer of rights rejected |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870170095261 DE 07/12/2017, DEVIDO AO DESPACHO PUBLICADO NA RPI 2529 DE 25/06/2019. |